Published in Mol Cell Biol on September 01, 1996
The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci U S A (1998) 2.10
Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol Cell Biol (2001) 2.00
Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J (2001) 1.93
RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol Cell Biol (1999) 1.86
Role of the LXCXE binding site in Rb function. Mol Cell Biol (2000) 1.77
C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol Cell Biol (2000) 1.74
Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev (2004) 1.72
ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation. EMBO J (1997) 1.71
The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle. Cell Div (2012) 1.46
Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol Cell Biol (1999) 1.42
zfh-1, the Drosophila homologue of ZEB, is a transcriptional repressor that regulates somatic myogenesis. Mol Cell Biol (1999) 1.22
Distinct mechanisms for repression of RNA polymerase III transcription by the retinoblastoma tumor suppressor protein. Mol Cell Biol (2004) 1.13
Transcription repression by Xenopus ET and its human ortholog TBX3, a gene involved in ulnar-mammary syndrome. Proc Natl Acad Sci U S A (1999) 1.09
Cellular mechanosensing: getting to the nucleus of it all. Prog Biophys Mol Biol (2014) 0.99
The Rb family contains a conserved cyclin-dependent-kinase-regulated transcriptional repressor motif. Mol Cell Biol (1996) 0.97
Induction of DNA synthesis and apoptosis by regulated inactivation of a temperature-sensitive retinoblastoma protein. EMBO J (1998) 0.94
Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function. Genes Cancer (2012) 0.93
Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft. Proc Natl Acad Sci U S A (2001) 0.91
Distinct roles for p107 and p130 in Rb-independent cellular senescence. Cell Cycle (2008) 0.88
Positive regulation of minichromosome maintenance gene expression, DNA replication, and cell transformation by a plant retinoblastoma gene. Proc Natl Acad Sci U S A (2009) 0.86
Rb inhibits the intrinsic kinase activity of TATA-binding protein-associated factor TAFII250. Mol Cell Biol (1999) 0.82
Restriction beyond the restriction point: mitogen requirement for G2 passage. Cell Div (2006) 0.80
The nuclear protein ALY binds to and modulates the activity of transcription factor E2F2. Mol Cell Proteomics (2013) 0.80
APC/C and retinoblastoma interaction: cross-talk of retinoblastoma protein with the ubiquitin proteasome pathway. Biosci Rep (2016) 0.75
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96
Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev (1995) 13.66
E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (1992) 10.28
The E2F transcription factor is a cellular target for the RB protein. Cell (1991) 9.62
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61
Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93
Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell (1991) 6.55
Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell (1989) 6.46
The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell (1989) 6.43
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54
Retinoblastoma protein switches the E2F site from positive to negative element. Nature (1992) 5.47
Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev (1993) 5.32
Structural evidence for the authenticity of the human retinoblastoma gene. Science (1987) 4.67
Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature (1991) 4.62
Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev (1992) 4.56
Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci U S A (1992) 4.27
Mechanism of active transcriptional repression by the retinoblastoma protein. Nature (1995) 4.05
Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell (1990) 3.77
Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science (1989) 3.63
Initiation of transcription by RNA polymerase II: a multi-step process. Prog Nucleic Acid Res Mol Biol (1993) 3.61
Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev (1993) 3.41
Tumor suppressor genes. Cell (1991) 3.36
DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci (1994) 3.32
The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell (1990) 3.19
The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev (1993) 3.10
Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets. Nature (1990) 3.03
The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci U S A (1993) 2.90
The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J (1990) 2.80
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol (1992) 2.78
GAL4 fusion vectors for expression in yeast or mammalian cells. Gene (1992) 2.76
Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell (1995) 2.70
A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci U S A (1990) 2.46
Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (1992) 2.39
Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol Cell Biol (1990) 2.27
Cell cycle checkpoints. Curr Opin Cell Biol (1994) 2.26
Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J (1990) 2.26
A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci U S A (1995) 2.17
Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol (1992) 2.13
Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol Cell Biol (1995) 2.13
Functional dissection of TFIIB domains required for TFIIB-TFIID-promoter complex formation and basal transcription activity. Nature (1993) 2.10
Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene (1993) 1.99
Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol (1993) 1.98
The transcription factor E2F-1 is a downstream target of RB action. Mol Cell Biol (1995) 1.97
Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell (1995) 1.92
Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol Cell Biol (1993) 1.64
Molecular characterization of the retinoblastoma susceptibility gene. Biochim Biophys Acta (1993) 1.55
Delineation of two functional regions of transcription factor TFIIB. Proc Natl Acad Sci U S A (1993) 1.55
The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J Biol Chem (1995) 1.46
The adenovirus E1A transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site. J Virol (1991) 1.14
Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site. Oncogene (1992) 0.97
Interaction of a common factor with ATF, Sp1, or TATAA promoter elements is required for these sequences to mediate transactivation by the adenoviral oncogene E1a. Mol Cell Biol (1992) 0.90
Cancer genetics. Curr Opin Genet Dev (1994) 0.85
Rb interacts with histone deacetylase to repress transcription. Cell (1998) 7.22
The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev (2000) 5.93
Retinoblastoma protein switches the E2F site from positive to negative element. Nature (1992) 5.47
A receptor in pituitary and hypothalamus that functions in growth hormone release. Science (1996) 5.45
Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell (1999) 4.94
Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell (2000) 4.48
Mechanism of active transcriptional repression by the retinoblastoma protein. Nature (1995) 4.05
Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol (2000) 2.84
Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell (1992) 2.67
ZEB represses transcription through interaction with the corepressor CtBP. Proc Natl Acad Sci U S A (1999) 2.64
Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell (1999) 2.48
Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem (1992) 2.37
Cloning and analysis of the promotor region of the human fibronectin gene. Proc Natl Acad Sci U S A (1987) 2.10
Role of the LXCXE binding site in Rb function. Mol Cell Biol (2000) 1.77
Linking the Rb and polycomb pathways. Mol Cell (2001) 1.76
Differential expression and function of members of the zfh-1 family of zinc finger/homeodomain repressors. Proc Natl Acad Sci U S A (2000) 1.73
ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation. EMBO J (1997) 1.71
A 5'-flanking sequence essential for progesterone regulation of an ovalbumin fusion gene. Nature (1983) 1.70
Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J Clin Invest (1995) 1.37
Chromatin remodeling and Rb activity. Curr Opin Cell Biol (2000) 1.30
Independent repressor domains in ZEB regulate muscle and T-cell differentiation. Mol Cell Biol (1999) 1.29
c-Myb and Ets proteins synergize to overcome transcriptional repression by ZEB. EMBO J (1997) 1.26
Rb-mediated chromatin structure regulation and transcriptional repression. Oncogene (2001) 1.26
zfh-1, the Drosophila homologue of ZEB, is a transcriptional repressor that regulates somatic myogenesis. Mol Cell Biol (1999) 1.22
Interferon regulatory factor-2 is a transcriptional activator in muscle where It regulates expression of vascular cell adhesion molecule-1. J Cell Biol (1998) 1.22
Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J Biol Chem (1997) 1.19
Transcriptional repression and growth suppression by the p107 pocket protein. Mol Cell Biol (1996) 1.18
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine. Drug Metab Dispos (2000) 1.18
Isolation of type IV procollagen-like polypeptides from glomerular basement membrane. Characterization of pro-alpha 1(IV). J Biol Chem (1983) 1.11
Expanding roles for alpha 4 integrin and its ligands in development. Cell Adhes Commun (1994) 1.10
Definition of the ovalbumin gene promoter by transfer of an ovalglobin fusion gene into cultured cells. Nucleic Acids Res (1983) 1.08
Chromatin remodeling and transcriptional regulation. J Natl Cancer Inst (1999) 1.04
Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites. Drug Metab Dispos (1999) 1.01
The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs. Drug Metab Dispos (2000) 1.00
Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium. Proc Natl Acad Sci U S A (1993) 0.97
The Rb family contains a conserved cyclin-dependent-kinase-regulated transcriptional repressor motif. Mol Cell Biol (1996) 0.97
A similar 5'-flanking region is required for estrogen and progesterone induction of ovalbumin gene expression. J Biol Chem (1984) 0.97
Characterization of three different elements in the 5'-flanking region of the fibronectin gene which mediate a transcriptional response to cAMP. J Biol Chem (1991) 0.96
An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter. J Biol Chem (1994) 0.96
Mitral regurgitation in coronary artery disease. Chest (1982) 0.95
Rocks in the right ventricle. A complication of congenital right ventricular infundibular obstruction associated with chronic pulmonary parenchymal disease. Am J Cardiol (1969) 0.93
A photoactivatable prenylated cysteine designed to study isoprenoid recognition. J Am Chem Soc (2001) 0.93
Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Mol Endocrinol (1998) 0.91
The alpha 5 beta 1 fibronectin receptor. Characterization of the alpha 5 gene promoter. J Biol Chem (1991) 0.91
Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride. Drug Metab Dispos (1995) 0.90
Operation for cardiac complications following myocardial infarction. Surgery (1970) 0.90
Interaction of a common factor with ATF, Sp1, or TATAA promoter elements is required for these sequences to mediate transactivation by the adenoviral oncogene E1a. Mol Cell Biol (1992) 0.90
Improved exercise performance following single daily dose of atenolol in stable angina. Int J Cardiol (1983) 0.87
Transcriptional repression by RB-E2F and regulation of anchorage-independent survival. Mol Cell Biol (2001) 0.85
Congenital quadricuspid aortic valve. Am J Cardiol (1966) 0.85
Characterization of the alpha 4 integrin gene promoter. Proc Natl Acad Sci U S A (1991) 0.84
Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol (1996) 0.84
Interaction of diclofenac and quinidine in monkeys: stimulation of diclofenac metabolism. J Pharmacol Exp Ther (1999) 0.84
Aspergillus infection after cardiac surgery. Arch Surg (1970) 0.84
Bovine glomerular basement membrane. Characterization of an alpha-size collagenous polypeptide. J Biol Chem (1981) 0.83
Corepressors and retinoblastoma protein function. Curr Top Microbiol Immunol (2001) 0.82
Long-term survival after coronary bypass surgery. Comparison of various subsets of patients with general population. Br Heart J (1981) 0.79
Chronic atrial fibrillation and coronary artery disease. J Electrocardiol (1978) 0.79
Control of vascular cell adhesion molecule-1 gene promoter activity during neural differentiation. J Biol Chem (1995) 0.79
Synthesis, chemistry, and antineoplastic activity of alpha-halopyridinium salts: potential pyridone prodrugs of acylated vinylogous carbinolamine tumor inhibitors. J Med Chem (1990) 0.78
Identification of a protein that interacts with the nuclear factor-1 (NF-1) binding site in cells that do not express NF-1: comparison to NF-1, cellular distribution, and effect on transcription. Nucleic Acids Res (1991) 0.78
Excision of akinetic left ventricular wall for intractable heart failure. Ann Intern Med (1969) 0.78
Assessing and minimizing time-dependent inhibition of cytochrome P450 3A in drug discovery: a case study with melanocortin-4 receptor agonists. Xenobiotica (2008) 0.78
Immunohistochemistry of types I and II collagen in undecalcified skeletal tissues. J Histochem Cytochem (1983) 0.76
Effect of left ventricular aneurysmectomy on exercise performance. Int J Cardiol (1984) 0.75
Intestinal basement membrane of Ascaris suum. Molecular organization and properties of the collagen molecules. J Biol Chem (1986) 0.75
Importance of mechanistic drug metabolism studies in support of drug discovery: A case study with an N -sulfonylated dipeptide VLA-4 antagonist in rats. Xenobiotica (2008) 0.75
Intermittent vertebral arteriovenous fistula, due to cervical stab wound. N Y State J Med (1972) 0.75
Silent mitral stenosis with atrial fibrillation. Detected by echocardiography. N Y State J Med (1977) 0.75
Aspergillus endocarditis of mitral prosthesis. Am J Cardiol (1968) 0.75
The potential for CYP2D6 inhibition screening using a novel scintillation proximity assay-based approach. J Biomol Screen (2001) 0.75